Cataract and Refractive Surgery

Cataract and Refractive Surgery News

  • AAP Updates Screening Policy for ROP A policy statement from the American Academy of Pediatrics provides updated guidelines for screening and treating retinopathy of prematurity (ROP).
  • Alert FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion.
 

Cataract and Refractive Surgery Perspective

 

Journals